Articles On Telix Pharmaceuticals (ASX:TLX)

The S&P/ASX 200 Index (ASX: XJO) endured a calamitous day on the markets this Thursday, reversing all of yesterday's gains and pushing the market and many ASX shares decisively lower. After opening sharply lower compared to yesterday's...

Highlights Technical scans highlight strong momentum across technology, resources and cybersecurity-focused stocks. Several well-known healthcare, banking and property names continue appearing on downtrend watchlists. NextDC, Codan an...

At the start of each week, I like to look at ASIC's short position report to find out which ASX shares are being targeted by short sellers. That's because I believe it is worth keeping a close eye on short interest levels as high levels c...

The ASX healthcare sector falls 0.197% this week as broader market rises 0.7% Vitrafy receives US Army validation that its cryopreservation ecosystem can freeze and thaw blood platelets without washing step June set to be a big month for A...

The S&P/ASX 200 Index (ASX: XJO) tumbled 1.4% on Thursday, continuing its recent volatile run.  It has been increasingly difficult to predict the market in 2026, as inflation, geopolitical uncertainty and CPI data have all sent the m...

Highlights ASX weakened as global risk concerns rose. Gold miners faced broad pressure. Defensive sectors showed relative resilience. The Australian share market ended weaker as global tensions, firmer oil prices, and...

Healthcare is one of my favourite long-term investment themes. The world is ageing, medical technology keeps improving, and patients are demanding better diagnosis, treatment, and care. That does not mean every healthcare share will do w...

A US$7 billion takeover rumoured to be on foot in the US could give investors a better sense of the upside in Telix Pharmaceuticals Ltd (ASX: TLX) shares, according to the team at Morgan Stanley. Takeover talks behind closed doors Bl...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha...

Highlights Market weakness deepens across key ASX-listed sectors Mining, healthcare and retail names remain under pressure Traders continue targeting heavily battered companies Australian equities remained volatile as several majo...

Highlights Several heavily watched Australian shares remained under pressure as market sentiment shifted across mining, healthcare, technology, and consumer sectors. Uranium-linked companies and growth-focused businesses continued to f...

Highlights Several high-profile ASX-listed companies are attracting fresh market attention across energy, technology, healthcare, and lithium sectors. Traders are closely monitoring technical momentum and sector rotation trends a...

At the start of each week, I like to look at ASIC's short position report to find out which ASX shares are being targeted by short sellers. That's because I believe it is worth keeping a close eye on short interest levels as high levels c...

Share price falls can be uncomfortable, especially when they happen to businesses that once had much stronger market confidence. But I do not think every fall should be treated the same way. Sometimes a falling share price points to a br...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Overseas markets rallied higher on the prospect of yet another temporary peace deal...

Highlights ASX rebounds strongly amid easing global tensions Banking and healthcare shares support market recovery Investor sentiment improves on resilient local demand Australian equities staged a sharp rebound as imp...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin IPAX-2 study of TLX101-Tx (¹³¹I-iodofalan) has completed patient enrolment. Maxi...

Highlights Short interest stays active across ASX mining and tech shares Rare earth and uranium companies remain under close watch Several ASX consumer and financial stocks attract renewed attention Short selling activ...

Highlights Uranium, healthcare, retail, and biotech shares are facing renewed market scrutiny across the Australian equities landscape. Several heavily watched companies are dealing with operational pressure, softer sentiment, and ongo...

Beating the market over 10 years is not easy. A company needs more than a good story. It needs a large opportunity, strong execution, and enough room to keep growing after the first wave of investor excitement has passed. I think th...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Highlights Investor activity intensified across energy, healthcare, technology, and ETF-focused market segments during April Inflation concerns and structural economic pressures continued shaping portfolio allocation strategies Semico...

Some ASX healthcare shares are going through a brutal period as competition, weaker demand and broader market pressures hammer investor confidence. CSL Ltd (ASX: CSL) has dominated headlines recently for all the wrong reasons, but other...

Presentations at specialist medical conferences along with publications in peer-reviewed journals offer important validation for ASX healthcare companies Alterity is presenting updates on ATH434, its Phase III-ready asset for MSA, at inter...

Highlights Mining stocks lifted market sentiment despite broader weakness Banking shares faced pressure ahead of the federal budget Copper rally pushed major resource companies higher The ASX 200 moved lower as investo...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Highlights Mining and banking shares weighed heavily on market sentiment. Geopolitical uncertainty kept investors cautious across sectors. Defensive sectors attracted attention amid broader market weakness. The ASX 200...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin The Australian market stumbled over the second half of April as inflation concerns r...

Gold has been one of the standout trades of the past year, and I can understand why investors have been drawn to it. When economic worries rise, geopolitical risks increase, and markets feel uncertain, gold often attracts attention. It c...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Highlights Mining stocks lift broader market sentiment Lithium and rare earth shares regain traction Most sectors close in positive territory The Australian market staged a recovery led by strong momentum in resource s...

At The Bell — The April tailspin is worsening Down Under again, with the Australian share market now heading for a -0.7% drop that would solidify a seventh consecutive day of retreats and bring us to ~8,600 points. Listen to the HotCoppe...

The S&P/ASX 200 Index (ASX: XJO) has tumbled again in early morning trade on Wednesday as inflation fears, interest rate hike concerns, and surging oil prices continue to put pressure on Australian stocks across several sectors. Dur...

Highlights Telix emerges as the most shorted stock on the ASX, overtaking Domino’s Pizza 4DMedical records a sharp rise in bearish positioning amid valuation focus Several technology, travel, and resource stocks reflect shifting short...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, April 28, 2026 /PRNewswire/ — Telix Pharma...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

It was a lacklustre finish to what has been a rather rough trading week for the S&P/ASX 200 Index (ASX: XJO) this Friday. After a shaky and volatile session that saw the index whipsaw quite a lot, the ASX 200 ended up closing 0.078% low...

Highlights Sharp sell-offs bring major names back into focus Short-term challenges contrast with long-term narratives Sector-specific factors driving recent volatility   Cochlear, Treasury Wine Estates, and Telix have faced recen...

It has been a rough period for a number of high-quality ASX 200 shares. Some have sold off heavily on short-term concerns, even though their longer-term outlooks still look intact. When that happens, I think it is worth taking a closer l...

Last week’s flurry of action at the radiopharmaceuticals leader Telix Pharmaceuticals (ASX:TLX) provided plenty of food for thought – and investors don’t know quite how to digest it. On the Monday, the stock surged up to 8.8% on news of a t...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are all over the place. The ASX biotech stock is down 5% over the past five trading days, yet up 16% over the past month and 27% year to date. Zoom out further and the picture flips again. Teli...

Finding ASX shares that can genuinely scale over time is not always easy. A lot of companies talk about big opportunities, but only a handful actually build the foundations needed to turn that potential into long-term growth.  I th...

A gaggle of drug developers is due to disclose company-making clinical study results this year While late-stage clinical trial victory does not confer commercial success, the results tend to be ‘do or die’ In the main, share valuations don...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are in the red in Tuesday lunchtime trade. At the time of writing the shares are down 1.7% to $14.50. Despite today's decline, the ASX biopharmaceutical company's shares have rebounded a whoppi...

Investors often target blue-chip ASX 200 shares for lower volatility and consistent earnings.  It's often assumed that because these companies are well-established, there is limited upside.  However, here are some blue-chip stocks th...

Telix Pharmaceuticals has lodged a cleansing notice with the ASX regarding its recently announced US$600 million convertible bond offering, a regulatory filing that clears the way for future share issuance without requiring a prospectus. Th...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Australian biotechs are successfully turning promising science into a scalable, repe...

Highlights Short interest highlights shifting market sentiment Multiple ASX 200 names dominate the list Sector-wide concerns driving cautious positioning High short interest across ASX 200 stocks highlights cautious market sentime...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...